tiprankstipranks
Supernus Pharmaceuticals (SUPN)
NASDAQ:SUPN
US Market
SUPN
Supernus Pharmaceuticals
RESEARCH TOOLSreports
Want to see SUPN full AI Analyst Report?

Supernus Pharmaceuticals (SUPN) Income Statement

534 Followers

Supernus Pharmaceuticals Income Statement

Last quarter (Q4 2025), Supernus Pharmaceuticals's total revenue was $211.57M, an increase of 21.48% from the same quarter last year. In Q4, Supernus Pharmaceuticals's net income was $-4.11M. See Supernus Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 718.95M$ 661.82M$ 607.52M$ 667.24M$ 579.77M
Gross Profit
$ 644.39M$ 583.91M$ 523.74M$ 580.02M$ 504.71M
Operating Expenses
$ 681.25M$ 502.25M$ 529.01M$ 533.89M$ 418.69M
Depreciation and Amortization
$ 90.03M$ 80.41M$ 84.86M$ 85.54M$ 32.59M
EBITDA
$ 41.00M$ 178.28M$ 90.04M$ 153.36M$ 129.19M
Operating Income
$ -36.86M$ 81.67M$ -5.27M$ 46.12M$ 86.03M
Other Income/Expenses
$ -12.17M$ 16.20M$ 8.04M$ 14.62M$ -12.85M
Pretax Income
$ -49.03M$ 97.87M$ 2.77M$ 60.74M$ 73.17M
Net Income
$ -38.55M$ 73.86M$ 1.32M$ 60.71M$ 53.42M
Per Share Metrics
Basic EPS
$ -0.68$ 1.34$ 0.02$ 1.13$ 1.01
Diluted EPS
$ -0.68$ 1.32$ 0.02$ 1.04$ 0.98
Weighted Average Shares Outstanding
 56.45M 55.10M 54.54M 53.67M 53.10M
Weighted Average Shares Outstanding (Diluted)
 56.45M 55.96M 55.51M 61.68M 54.36M
Currency in USD

Supernus Pharmaceuticals Earnings and Revenue History